Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21732836 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Macitentan in Pulmonary Hypertension of Sickle Cell Disease
Conditions: Pulmonary Hypertension;   Sickle Cell Disease
Intervention: Drug: macitentan
2 Unknown  Evaluation of the Prevalence of Pulmonary Hypertension in Adult Patients With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention:

Indicates status has not been verified in more than two years